Pot marigold shows promise as functional food ingredient, but clinical evidence still lacking

Evidence-based scientific framing with appropriate caveats. The article frames pot marigold as 'promising' based on in vitro studies while explicitly noting the absence of clinical evidence in humans, avoiding overstatement of benefits.

Consumers interested in natural, plant-based functional foods may see pot marigold-infused products (yogurts, breads, oils) enter the market, but without clinical evidence, health claims will be limited and products positioned primarily as natural colorants or nutritional supplements rather than therapeutic foods.

Regulatory bodies (FDA, EFSA) will likely require clinical trials before allowing health claims on marigold-containing products. Companies may face restrictions on marketing claims until human efficacy data emerges. Potential for new functional food ingredient approvals if safety and efficacy standards are met.